Opto Circuits (India) is currently trading at Rs. 70.65, up by 3.60 points or 5.37% from its previous closing of Rs. 67.05 on the BSE.
The scrip opened at Rs. 67.60 and has touched a high and low of Rs. 71.40 and Rs. 67.60 respectively. So far 640833 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 225.38 on 17-Feb-2012 and a 52 week low of Rs. 65.30 on 06-Feb-2013.
Last one week high and low of the scrip stood at Rs. 73.40 and Rs. 65.30 respectively. The current market cap of the company is Rs. 1711.99 crore.
The promoters holding in the company stood at 28.17% while Institutions and Non-Institutions held 39.09% and 32.74% respectively.
Opto Circuits (India) has reported results for third quarter ended December 31, 2012.
The company has reported 0.38% fall in its net profit at Rs 60.18 crore for the quarter as compared to Rs 60.41 crore for the same quarter in the previous year. However, total income from operation of the company has increased by 17.42% at Rs 189.22 crore for quarter under review as compared to Rs 161.15 crore for the quarter ended December 31, 2011.
On consolidated basis, the company has reported 9.45% fall in its net profit at Rs 113.26 crore for the quarter as compared to Rs 125.08 crore for the same quarter in the previous year. However, total income from operation of the company has increased by 2.65% at Rs 623.12 crore for quarter under review as compared to Rs 607.04 crore for the quarter ended December 31, 2011.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: